Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 19, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.

Needs Beyond Medicine receives $10,000 grant from The Labcorp Charitable Foundation

SALT LAKE CITY, Utah, April 6, 2022 — Needs Beyond Medicine today announced the receipt of a $10,000 grant from The Labcorp Charitable Foundation in support of its Relief Program, which brings critical assistance to adults with cancer who are facing the fight of their lives.

Labcorp initiates quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 7, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. 

New Immundiagnostik test simplifies detecting, measuring unintentional gluten consumption

MANCHESTER, N.H., April 5, 2022 — Immundiagnostik, Inc., the North American subsidiary of Immundiagnostik AG, has collaborated with Labcorp (NYSE: LH), a leading global life sciences company, to help individuals detect and quantify unintentional gluten consumption by utilizing a new fecal gluten test. The quantitative test developed by Immundiagnostik and offered exclusively through Labcorp detects the presence of gluten in a patient’s stool sample and has a high sensitivity and specificity.

Labcorp renews strategic partnership with Medidata to provide suite of clinical trial technologies and services

NEW YORK, March 31, 2022 — Medidata, a Dassault Systèmes company, announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation of their initiative to co-develop digital biomarkers and expand the use and functionality of decentralized clinical trials.

Labcorp to announce first quarter financial results on April 28, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 28, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the first quarter of 2022 before the market opens on Thursday, April 28, 2022 . The company will host a conference call and webcast.

New Labcorp offering makes detecting, measuring unintentional gluten consumption simple and effective

Labcorp becomes first U.S. commercial laboratory to provide quantitative testing for gluten in stool samples BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 17, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is the first U.S. commercial laboratory to offer a new test developed by Immundiagnostik, Inc.

Report on data interoperability measures will be released at HIMSS22

WASHINGTON, March 14, 2022 — The Healthcare Leadership Council (HLC) will release a report on how to better measure progress toward health data interoperability at a March 16 breakfast event, hosted by Surescripts, in conjunction with the HIMSS Global Health Conference in Orlando, FL.

Labcorp enters into strategic relationship with Prisma Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, is entering into a strategic laboratory relationship with Prisma Health , a nonprofit and the largest health system in South Carolina.

Walgreens and Labcorp offer at-home COVID-19 PCR test collection kits at no cost nationwide

Collaboration expands access to convenient testing at no cost for eligible individuals DEERFIELD, Ill., and BURLINGTON, N.C., March 7, 2022 – Walgreens and Labcorp, a leading global life sciences company, today announced the nationwide [i] availability of Pixel by Labcorp® [ii] COVID-19 at-home collection kit, a PCR test available through Labcorp OnDemand™, at no cost to individuals who meet clinical guidelines*.